首页> 外国专利> METHODS AND COMPOSITIONS OF NATURAL KILLER CELL ADOPTIVE TRANSFER THERAPY

METHODS AND COMPOSITIONS OF NATURAL KILLER CELL ADOPTIVE TRANSFER THERAPY

机译:天然杀伤细胞适应性转移治疗的方法和组成

摘要

Disclosed are methods and compositions useful for treating patients with inflammatory, auto-immune and age related conditions. The disclosure relates to using Natural Killer cells and derivatives thereof in order to induce therapeutic benefit to patients affected by disease and conditions such as cancer, multiple sclerosis, rheumatoid arthritis, type I diabetes mellitus, thyroid autoimmune disease, psoriasis and inflammatory bowel diseases. In some embodiments the disclosure permits physiological compensation for disease conditions by reduction of inflammatory cytokine levels in plasma and of senescent peripheral blood mononuclear cells thereby prolonging the time until medical intervention may be required. In alternate embodiments the disclosure permits physiological compensation for disease conditions by reduction of inflammatory cytokine levels in plasma and reduction of senescent peripheral blood mononuclear cells following medical intervention.
机译:公开了可用于治疗炎性,自身免疫和与年龄有关的疾病的患者的方法和组合物。本公开涉及使用天然杀伤细胞及其衍生物以对受疾病和病症例如癌症,多发性硬化症,类风湿性关节炎,I型糖尿病,甲状腺自身免疫病,银屑病和炎性肠病影响的患者诱导治疗益处。在一些实施方案中,本公开允许通过减少血浆和衰老的外周血单核细胞中的炎性细胞因子水平来对疾病状况进行生理补偿,从而延长了直到可能需要医学干预的时间。在替代实施方案中,本公开允许通过减少血浆中的炎性细胞因子水平和在药物干预后减少衰老的外周血单核细胞来对疾病状况进行生理补偿。

著录项

  • 公开/公告号US2020138861A1

    专利类型

  • 公开/公告日2020-05-07

    原文格式PDF

  • 申请/专利权人 RESTEM LLC;

    申请/专利号US201816178369

  • 发明设计人 NICKOLAS CHELYAPOV;RAFAEL GONZALEZ;

    申请日2018-11-01

  • 分类号A61K35/17;A01N1/02;

  • 国家 US

  • 入库时间 2022-08-21 11:20:29

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号